RxDoctor Payments Data

Scott Salmon, DO

Urology · St George, UTNPI 1063687051

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 80.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $2,635 and has fallen 92.6% since, to $195 in 2025. That places this record below the midpoint for urology clinicians in UT, where the typical reported total is $3,296.

$3,296in general payments, 2019–2025

Across 39 payments — averaging $84.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Boston Scientific$212
  • Coloplast$75
  • Procept Biorobotics Corporation$72
  • Johnson & Johnson$43
  • Endo Pharmaceuticals Inc.$35
  • plus $194 from 8 others

What the payments were for

  • Travel & lodging$94129%
  • Food & beverage$81825%
  • Education$1,53747%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,296 in reported general payments places this provider in the 50th percentile of 96 urology providers in Utah.

See all urology providers in Utah

Medicare billing

Part B allowed, 2024
$262,154
Medicare patients
650
Services billed
3,970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron25$29,406
Tamsulosin Hcl454$6,152
Solifenacin Succinate123$5,739
Finasteride300$4,337
Oxybutynin Chloride147$1,312
Potassium Citrate ErPotassium Citrate18$1,248
Imipramine Hcl17$643
Ciprofloxacin Hcl96$610
Doxazosin Mesylate22$351
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen66$276
Bicalutamide19$255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$28$29,40625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 96 urology providers in Utah.

Other urology in St George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →